| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |